摘要
心脏手术围术期出血是常见的严重并发症。美国麻醉学会和胸外科学会2007年的统计发现，在冠状动脉旁路移植（CABG）围术期，大约2／3的病人需要输注红细胞悬液。心脏手术病人的用血量占医院总用血量的15％-30％。大量输注异体库血可造成血源性疾病传播，主要包括肝炎、HIV等，引起发热，增加感染概率，造成病人治疗费用增加，部分病人还可能出现输血反应。
出处
《中华胸心血管外科杂志》
CSCD
北大核心
2008年第4期281-283,共3页
Chinese Journal of Thoracic and Cardiovascular Surgery
参考文献14
-
1Society of Thoracic Surgeons Blood Conservation guideline Task Force, Ferraris VA, Frrafis SP, et al. Pefioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline. Ann Thorac Surg, 2007,83(5 Suppl) :S27 - S86.
-
2Brown JR, Birkmeyer NJ, O' Connor GT. Meta-analysis comparing the effectiveness and adverse outcomes of antifibrinolytic agents in cardiac surgery. Circulation,2007,115:2801 - 2813.
-
3Diprose P, Herbertson M], O'Shaughnessy D, et al. Reducing allogeneic transfusion in cardiac surgery: a randomized double-blind placebo-controlled trial of antifibrinolytic therapies used in addition to intra-operative cell salvage. Br J Anaesth,2005,94:271 - 278.
-
4Alderman EL, Levy JH, Rich JB, et al. Analyses of coronary graft patency after aprotinin use: results from the Intemational Multicenter Aprotinin Graft Patency Experience (IMAGE)trial. J Thorac Cardiovasc Surg, 1998,116:716 - 730.
-
5Sedrakyan A, Treasure T, Elefteriades JA. Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials. J Thorac Cardiovasc Surg, 2004,128:442-448.
-
6Henry DA, Moxey AJ, Carless PA, et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Coehrane Database Syst Rev,2001,1 : CD001886.
-
7Mora Mangano CT, Neville JM, Hsu PH, et al. Aprotinin, blood loss, and renal dysfunction in deep hypothermic circulatory arrest. Circulation, 2001,104( 12 Suppl 1 ) : I276 - I281.
-
8Furnary A_P, Wu Y, Hiratzka LF, et al. Aprotinin does not increase the risk of renal failure in cardiac surgery patients. Circulation,2007,116(11 Suppl) : I127 - I133.
-
9Mangano DT, Tudor IC, Dietzel C, et al. The risk associated with aprotinin in cardiac surgery. N Engl J Meal,2006,354:353- 365.
-
10Bridges CR. Valid comparisons of antifibrinolytic agents used in cardiac surgery. Circulation,2007, 115:2790 - 2792.
同被引文献6
-
1Mangano DT, Miao Y, Vuylsteke A, et al. Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery. JAMA, 2007,297 ( 5 ) : 471-479.
-
2Karkouti K, Beattie WS, Dattilo KM, et al. A propensity score casecontrol comparison of aprotinin and tranexamic acid in hightransfusion-risk cardiac surgery. Transfusion, 2006,46 ( 3 ) : 327- 338.
-
3Fergusson DA,Hebert PC,Mazer CD,et al. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med, 2008,358(22) :2319-2331.
-
4王现强,郑哲,敖虎山,张士举,王杨,张浩,李立环,胡盛寿.心脏外科停用抑肽酶前后围术期结果比较[J].中华胸心血管外科杂志,2009,25(2):88-92. 被引量：2
-
5刘建东,王刚.临床停用抑肽酶后的替代治疗[J].中国体外循环杂志,2009,7(3):185-188. 被引量：2
-
6黄焕雷,谢旭晶,卢聪,刘菁,彭东,肖学钧,庄建.抑肽酶停用后再次开胸止血的临床分析及对策[J].实用医学杂志,2010,26(12):2173-2175. 被引量：2
-
1尤国兴,赵莲,陈赣,王瑛,卢明子,李鹏龙,章金刚,周虹.不同时间输注红细胞悬液对大鼠失血性休克复苏的影响[J].中国输血杂志,2012,25(2):126-129. 被引量：3
-
2杨峻岭,陈明.氨甲环酸对单侧膝关节置换围术期出血的影响[J].包头医学院学报,2015,31(2):57-58.
-
3涂桂生.防治骨质疏松症药物研究进展（下）[J].化学医药工业信息,1995,11(8):5-10. 被引量：1
-
4刘向伟,邓西元,路彦伟,陈桂平.微创经皮肾镜取石术围术期出血的防治[J].山东医药,2012,52(19):72-73. 被引量：9
-
5魏舒.安定和芬太尼用于减轻心脏手术病人气管内插管副反应的比较[J].临床麻醉学杂志,1989,5(1):17-18. 被引量：1
-
6刘浩,李海清,张宇.经尿道前列腺电切术治疗前列腺增生并发出血34例临床体会[J].中国民族民间医药,2015,24(11):123-123. 被引量：1
-
7张林基,张元平.骨质疏松药物研究进展[J].西北国防医学杂志,2011,32(3):202-203. 被引量：5
-
8陈竹,余静,赵荣香,胡煜.小儿肝左叶假性动脉瘤破裂并胆道大出血一例[J].中国小儿急救医学,2015,22(9):665-666. 被引量：1
-
9李景兰.成分输血在急性创伤性骨折治疗中的应用[J].中国医学创新,2011,8(31):137-138. 被引量：1
-
10朱艳玲.老年人骨质疏松性骨折治疗药物研究进展[J].中国疗养医学,2009,18(8):722-723. 被引量：3
